Safety and Efficacy of Fenofibrate as a Treatment for Huntington's Disease
Status:
Active, not recruiting
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to study the safety and efficacy of fenofibrate, an
FDA-approved drug for high cholesterol and/or elevated triglyerides (fats), as a treatment
for Huntington's disease (HD). Subjects who meet the entry criteria will be randomized (3:1)
to either 145mg of fenofibrate or placebo.